Most Popular

Goldman Sachs Enhances Rating for Northern Trust Corporation’s Preferred Stock (NTRSO)

Goldman Sachs upgraded its outlook for Northern Trust Corporation – Preferred Stock (NasdaqGS: NTRSO) from Sell to Neutral on April 6, 2026. The average ...

Top Stocks to Avoid on April 7th

Three stocks have been added to the Zacks Rank #5 (Strong Sell) List as of today: AST SpaceMobile (ASTS), Amplify Energy (AMPY), and Arcosa ...

Cattle Markets Open the Week with Positive Momentum

Live cattle futures are on the rise, with April contracts increasing by $2.375 to reach $248.575 on First Notice Day. Cash cattle sales surged ...

Natural Gas Prices Surge with Predictions of Cold Weather in the US

On Monday, May Nymex natural gas closed up $0.011, or 0.39%, after recovering from a 7.25-month low. Forecasts for colder temperatures in the U.S. ...

Spotlight on Bear of the Day: Fortune Brands Innovation Inc. (FBIN)

Fortune Brands Innovation Inc. (FBIN) has seen its stock plummet nearly 30% year-to-date and over 50% from its 2021 highs, amid a challenging housing ...

Spruce Power Sees 2% Increase Despite Larger Yearly Loss in Q4

Spruce Power Holding Corporation (SPRU) reported a wider net loss of $6.9 million, or 38 cents per share, for Q4 2025, compared to a ...

Top 3 Construction and Mining Equipment Stocks to Monitor During Industry Challenges

The **Zacks Manufacturing – Construction and Mining** industry is experiencing challenges amid a contraction in the manufacturing sector, facing subdued customer spending and geopolitical ...

Piper Sandler Boosts Rating for Tyson Foods (TSN)

Piper Sandler upgraded Tyson Foods (NYSE: TSN) from Underweight to Neutral on February 4, 2025. The average one-year price target for the company is ...

BMO Capital Boosts Rating for Northern Trust (NTRS)

BMO Capital upgraded Northern Trust (NasdaqGS:NTRS) from Market Perform to Outperform on April 6, 2026. The average one-year price target for the company is ...

Citizens Begins Coverage of Avalo Therapeutics (AVTX) with Positive Market Outlook

On April 6, 2026, Citizens began coverage of Avalo Therapeutics (NasdaqCM: AVTX) with a “Market Outperform” recommendation. The average one-year price target for Avalo ...